Verastem (VSTM) Equity Average: 2018-2025

Historic Equity Average for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to $10.3 million.

  • Verastem's Equity Average fell 31.36% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 31.36%. This contributed to the annual value of $67.5 million for FY2022, which is 33.47% down from last year.
  • Verastem's Equity Average amounted to $10.3 million in Q3 2025, which was up 466.66% from $1.8 million recorded in Q2 2025.
  • Verastem's 5-year Equity Average high stood at $108.9 million for Q1 2021, and its period low was -$30.7 million during Q1 2025.
  • Its 3-year average for Equity Average is $26.3 million, with a median of $18.5 million in 2024.
  • In the last 5 years, Verastem's Equity Average soared by 67.40% in 2021 and then plummeted by 156.66% in 2025.
  • Verastem's Equity Average (Quarterly) stood at $91.6 million in 2021, then slumped by 39.82% to $55.1 million in 2022, then skyrocketed by 58.24% to $92.4 million in 2023, then tumbled by 83.81% to -$8.9 million in 2024, then crashed by 31.36% to $10.3 million in 2025.
  • Its Equity Average was $10.3 million in Q3 2025, compared to $1.8 million in Q2 2025 and -$30.7 million in Q1 2025.